Relay Therapeutics: Q1 Earnings Insights

Relay Therapeutics RLAY reported its Q1 earnings results on Thursday, May 4, 2023 at 04:05 PM.

Here's what investors need to know about the announcement.

Relay Therapeutics missed estimated earnings by 13.04%, reporting an EPS of $-0.78 versus an estimate of $-0.69.

Revenue was down $193 thousand from the same period last year.

Last quarter the company beat on EPS by $0.14 which was followed by a 2.12% drop in the share price the next day.

Here's a look at Relay Therapeutics's past performance:

Quarter	Q4 2022	Q3 2022	Q2 2022	Q1 2022
EPS Estimate	-0.70	-0.71	-0.63	-0.62
EPS Actual	-0.56	-0.76	-0.71	-0.57
Revenue Estimate	3.30M	1.66M	1.93M	170K
Revenue Actual	253K	344K	365K	419K

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Relay Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar